{"Abstract": [0], "The": [1, 48], "outbreak": [2], "of": [3, 21, 30, 71, 126, 168], "Coronavirus": [4], "Disease": [5], "2019": [6, 44], "(COVID-19)": [7], "has": [8], "posed": [9], "a": [10, 67], "serious": [11], "threat": [12], "to": [13, 96, 112, 132, 139, 161], "global": [14], "public": [15], "health,": [16], "calling": [17], "for": [18, 69, 166], "the": [19, 54, 80, 91, 121, 159], "development": [20, 70], "safe": [22], "and": [23, 26, 62, 64, 75, 88, 98, 118, 129, 151, 170], "effective": [24], "prophylactics": [25], "therapeutics": [27], "against": [28], "infection": [29, 138], "its": [31], "causative": [32], "agent,": [33], "severe": [34], "acute": [35], "respiratory": [36], "syndrome": [37], "coronavirus": [38, 46], "2": [39, 102], "(SARS-CoV-2),": [40], "also": [41], "known": [42], "as": [43, 66], "novel": [45], "(2019-nCoV).": [47], "CoV": [49], "spike": [50], "(S)": [51], "protein": [52, 87, 93], "plays": [53], "most": [55], "important": [56], "roles": [57], "in": [58, 84], "viral": [59], "attachment,": [60], "fusion": [61], "entry,": [63], "serves": [65], "target": [68], "antibodies,": [72], "entry": [73], "inhibitors": [74], "vaccines.": [76], "Here,": [77], "we": [78], "identified": [79], "receptor-binding": [81], "domain": [82], "(RBD)": [83], "SARS-CoV-2": [85, 105, 127, 148, 169], "S": [86], "found": [89], "that": [90], "RBD": [92, 106, 117, 128, 131, 149], "bound": [94], "strongly": [95], "human": [97], "bat": [99], "angiotensin-converting": [100], "enzyme": [101], "(ACE2)": [103], "receptors.": [104], "exhibited": [107], "significantly": [108], "higher": [109], "binding": [110, 122], "affinity": [111], "ACE2": [113], "receptor": [114], "than": [115], "SARS-CoV": [116, 130, 142, 152, 163, 171], "could": [119, 145, 155], "block": [120], "and,": [123], "hence,": [124], "attachment": [125], "ACE2-expressing": [133], "cells,": [134], "thus": [135], "inhibiting": [136], "their": [137], "host": [140], "cells.": [141], "RBD-specific": [143], "antibodies": [144], "cross-react": [146], "with": [147], "protein,": [150], "RBD-induced": [153], "antisera": [154], "cross-neutralize": [156], "SARS-CoV-2,": [157], "suggesting": [158], "potential": [160], "develop": [162], "RBD-based": [164], "vaccines": [165], "prevention": [167], "infection.": [172]}